
NovoCure Limited NVCR
$ 16.62
9.27%
Annual report 2025
added 02-26-2026
NovoCure Limited P/E Ratio 2011-2026 | NVCR
Annual P/E Ratio NovoCure Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11.2 | -12.4 | -7.83 | -88.9 | -133 | 3.59 K | -1.15 K | -68.1 | -32.7 | -3.96 | -3.4 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.59 K | -1.15 K | 189 |
P/E Ratio of other stocks in the Health care industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
17.2 | - | -2.32 % | $ 107 B | ||
|
CVS Health Corporation
CVS
|
54.2 | $ 82.09 | -1.45 % | $ 104 B | ||
|
Triple-S Management Corporation
GTS
|
8.04 | - | 0.28 % | $ 847 M | ||
|
Magellan Health, Inc.
MGLN
|
6.34 | - | -0.19 % | $ 2.49 B | ||
|
UnitedHealth Group Inc.
UNH
|
22.2 | $ 368.78 | -0.46 % | $ 335 B | ||
|
Centene Corporation
CNC
|
-3.06 | $ 53.34 | -0.61 % | $ 26.3 B | ||
|
Molina Healthcare
MOH
|
14.1 | $ 192.7 | -0.99 % | $ 10.2 B | ||
|
Cigna Corporation
CI
|
12.8 | $ 282.9 | -2.7 % | $ 74.5 B | ||
|
Humana
HUM
|
19.4 | $ 233.63 | -1.29 % | $ 28.1 B |